Rolapitant

BNF:
Not listed
Status:
Red
Decision Date:
July 2017
 

Comments

RED: prevention of delayed nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy in adults.

NHS England drug. To be used in line with NHS England commissioning intentions.

search again